-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, E2Tj80bV9wtGiP4ot2rGIdnjwhLpyU1jDT4lhbPZX6i7klk5KQ+ejaQRV0DOescT GhPB6BnP5nPvVDLQLTAd1w== 0001181431-08-040967.txt : 20080630 0001181431-08-040967.hdr.sgml : 20080630 20080630185258 ACCESSION NUMBER: 0001181431-08-040967 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20080626 FILED AS OF DATE: 20080630 DATE AS OF CHANGE: 20080630 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Kim Helen Susan CENTRAL INDEX KEY: 0001422772 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-31633 FILM NUMBER: 08927255 BUSINESS ADDRESS: BUSINESS PHONE: (510) 731-5270 MAIL ADDRESS: STREET 1: 3832 BAY CENTER PLACE CITY: HAYWARD STATE: CA ZIP: 94545 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: KOSAN BIOSCIENCES INC CENTRAL INDEX KEY: 0001110206 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH [8731] IRS NUMBER: 943217016 STATE OF INCORPORATION: CA FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 3832 BAY CENTER PLACE CITY: HAYWARD STATE: CA ZIP: 94545 BUSINESS PHONE: 5107328400 MAIL ADDRESS: STREET 1: 3832 BAY CENTER PLACE CITY: HAYWARD STATE: CA ZIP: 94545 4 1 rrd211767.xml KIM FORM 4 (ACQUISITION) X0303 4 2008-06-26 1 0001110206 KOSAN BIOSCIENCES INC KOSN 0001422772 Kim Helen Susan 3832 BAY CENTER PLACE HAYWARD CA 94545 0 1 0 0 President and CEO Common Stock 2008-06-26 4 J 1 16000 D 0 D Employee Stock Option (Right to Buy) 3.54 2008-06-26 4 D 0 140000 D 2018-01-03 Common Stock 140000 0 D Employee Stock Option (Right to Buy) 1.71 2008-06-26 4 D 0 50000 D 2018-04-01 Common Stock 50000 0 D Restricted Stock Units 2008-06-26 4 D 0 15100 D Common Stock 15100 0 D Each share of Common Stock disposed of pursuant to Agreement and Plan of Merger, dated as of May 28, 2008, among the Issuer, Bristol-Myers Squibb Company and KB Acquisition Corp. (the "Merger Agreement") in exchange for $5.50 per share in cash. Option disposed of pursuant to the Merger Agreement in exchange for an amount in cash equal to (A) the excess, if any of (1) $5.50 over (2) the exercise price per share of Issuer Common Stock subject to such option, multiplied by (B) the number of shares of Issuer Common Stock subject to such option immediately prior to the effective time of the merger (whether vested or unvested). Each restricted stock unit (an "RSU") represents a contingent right to receive one share of the Common Stock of the Issuer. Each RSU that was outstanding immediately prior to the effective time of the merger was, with the holder of such RSU receiving in full satisfaction of the rights of such holder with respect thereto, an amount in cash equal to $5.50 multiplied by the maximum number of shares of Issuer Common Stock subject to such RSU immediately prior to the effective time of the merger. Jonathan K. Wright, Attorney-in-Fact 2008-06-26 -----END PRIVACY-ENHANCED MESSAGE-----